Clinical Trial Update: A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SHR-1316 as maintenance therapy in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• SHR-1316

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Limited-stage Small Cell Lung Cancer, LS-SCLC | Phase 2 | Status: UNKNOWN